Form 4 for PFE Pfizer
Accepted 2026-02-27 00:00:00 ET · period of report 2026-02-25 · accession 0001225208-26-002818 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-02-27 | 2026-02-25 | PFE | BOURLA ALBERT | COB, CEO, Dir | F - Tax | $26.92 | -475.5K | 388.7K | -55% | -$12.80M |
| D | 2026-02-27 | 2026-02-25 | PFE | BOURLA ALBERT | COB, CEO, Dir | M - OptEx | $33.82 | +491.6K | 864.2K | +132% | +$16.63M |
| D | 2026-02-27 | 2026-02-25 | PFE | BOURLA ALBERT | COB, CEO, Dir | M - OptEx | $0.00 | -491.6K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-25 | F | D | 8,303 | $27.09 | 855,912 | D | — | — | (F2) The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights. |
| 2 | Common | Common Stock | 2026-02-25 | M | A | 491,626 | $33.82 | 864,215 | D | — | — | (F1) The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon). |
| 3 | Common | Common Stock | 2026-02-25 | F | D | 467,241 | $26.92 | 388,671 | D | — | — | (F3) The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon). (F4) Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used. |
| 4 | Derivative | Stock Appreciation Rights | 2026-02-25 | M | D | 491,626 | $0.00 | 0 | D | $33.82 · 2026-02-25 to 2026-02-25 | 491,626 Common Stock |